UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052895
Receipt number R000060355
Scientific Title Non-interventional prospective observational study: changes in hepatic profile with standard treatment of hypertriglyceridemia-associated MASLD
Date of disclosure of the study information 2023/11/24
Last modified on 2023/11/24 18:14:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Non-interventional prospective observational study: changes in hepatic profile with standard treatment of hypertriglyceridemia-associated MASLD

Acronym

Non-interventional prospective observational study: changes in hepatic profile with standard treatment of hypertriglyceridemia-associated MASLD

Scientific Title

Non-interventional prospective observational study: changes in hepatic profile with standard treatment of hypertriglyceridemia-associated MASLD

Scientific Title:Acronym

Non-interventional prospective observational study: changes in hepatic profile with standard treatment of hypertriglyceridemia-associated MASLD

Region

Japan


Condition

Condition

Hypertriglyceridemia complicated MASLD

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective is to prospectively identify clinical markers and hepatic pathological changes in hypertriglyceridemia-associated MASLD as affected by the current standard treatment of hypertriglyceridemia: diet, exercise, and fibrate therapy.

Basic objectives2

Others

Basic objectives -Others

The objective is to prospectively identify changes in liver signaling pathways in hypertriglyceridemia-associated MASLD as affected by current standard therapy.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in liver histology (fibrosis stage and NAS) from time of enrollment to 52 weeks or later.

Key secondary outcomes

Percentage and amount of change in laboratory values from enrollment to 52 weeks or later (TG, TC, HDL-C, LDL-C (direct method), WBC, RBC, Hb, Plt, PT%, TP, Alb, BUN, Cre, eGFR, Na, K, Cl, T-Bil, D-Bil, I-Bil, AST, ALT, AFP, AFP- L3, PIVKA-II, type 4 C7S, M2BPGi, Autotaxin, etc.),Changes in imaging findings from enrollment to 52 weeks or later: CT values, MRI (PDFF values, elastography values) US (presence of fatty liver), Fibroscan (CAP values, E values),Changes in body composition from the time of enrollment to 52 weeks or later: InBody,Liver signaling pathway (Single-nucleus RNA-seq analysis, Quantitative PCR, Western blotting, immunohistochemistry),Adverse events.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Hypertriglyceridemic patients between the ages of 20 and 80 years who have been diagnosed with MASLD by the NASH Clinical Research Network classification on liver biopsy and whose disease status will be evaluated by multiple liver biopsies.
Patients who meet the above criteria and have started standard treatment (diet, exercise, and fibrate therapy).

Key exclusion criteria

Cases in which written consent to participate in the study cannot be obtained.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Takeji
Middle name
Last name Umemura

Organization

Shinshu University

Division name

Gastroenterology

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto City, Nagano Prefecture

TEL

81263372644

Email

t-umemura@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Takefumi
Middle name
Last name Kimura

Organization

Shinshu University

Division name

Gastroenterology

Zip code

3908621

Address

3-1-1 Asahi, Matsumoto City, Nagano Prefecture

TEL

81263372644

Homepage URL


Email

t_kimura@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University

Institute

Department

Personal name



Funding Source

Organization

Others

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University School of Medicine Ethics Committee

Address

3-1-1 Asahi-, Matsumoto City, Nagano Prefecture

Tel

81263372644

Email

t_kimura@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 11 Month 14 Day

Date of IRB

2023 Year 11 Month 14 Day

Anticipated trial start date

2023 Year 11 Month 24 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Conducted at Shinshu University.


Management information

Registered date

2023 Year 11 Month 24 Day

Last modified on

2023 Year 11 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060355


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name